THE ANTICOAGULANT AND ANTILYMPHOMA PROPERTIES OF ARSENIC AZOPROTEINS
Open Access
- 1 September 1964
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 120 (3) , 449-466
- https://doi.org/10.1084/jem.120.3.449
Abstract
Experiments in this paper have shown that 4-arsonophenylazoproteins possess marked anticoagulant activity both in vivo and in vitro. Two acidic azoproteins that are devoid of arsenic[long dash]namely 4-carboxyphenylazoprotein and 4-sulfono-phenylazoprotein[long dash]have marked anticoagulant effects in vitro, but they had no inhibitory action against cells of Lymphoma 6C3HED in vivo, even when they were given to mice in maximum tolerated amounts. The essential part played by arsenic in the antilymphoma activity of arsenic azoproteins is further emphasized by the action of dimercaprol (BAL) in preventing the antilymphoma effects of 4-arsonophenylazo-protein on Lymphoma 6C3HED cells in vivo.This publication has 5 references indexed in Scilit:
- EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTSThe Journal of Experimental Medicine, 1963
- AZOPROTEINS .1. SPECTROPHOTOMETRIC STUDIES OF AMINO ACID AZO DERIVATIVES1959
- EFFECTS OF ARSENIC-AZOPROTEINS ON MOUSE LYMPHOMA CELLS IN VIVOThe Journal of Experimental Medicine, 1958
- The reactions of diazonium compounds with amino acids and proteinsBiochemical Journal, 1957
- Comparative Effectiveness of Five Newly Synthesized Arsenical Compounds in Treatment of Leukemia in MiceExperimental Biology and Medicine, 1952